RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 127 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $466,913 | -86.5% | 20,367 | -89.5% | 0.00% | -88.2% |
Q1 2023 | $3,453,646 | -39.2% | 193,590 | -0.7% | 0.02% | -46.9% |
Q4 2022 | $5,678,284 | -4.8% | 194,996 | -19.9% | 0.03% | 0.0% |
Q3 2022 | $5,963,000 | +2699.5% | 243,408 | +3292.4% | 0.03% | +1500.0% |
Q4 2020 | $213,000 | -73.4% | 7,175 | -80.6% | 0.00% | -71.4% |
Q3 2020 | $801,000 | – | 36,969 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |